Tivic Health Systems Inc (TIVC)
0.262
+0.01
(+2.30%)
USD |
NASDAQ |
Sep 27, 16:00
0.2562
-0.01
(-2.21%)
After-Hours: 20:00
Tivic Health Systems Research and Development Expense (TTM): 1.255M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.255M |
| March 31, 2024 | 1.421M |
| December 31, 2023 | 1.655M |
| September 30, 2023 | 1.73M |
| June 30, 2023 | 1.792M |
| March 31, 2023 | 1.821M |
| Date | Value |
|---|---|
| December 31, 2022 | 1.732M |
| September 30, 2022 | 1.61M |
| June 30, 2022 | 1.386M |
| March 31, 2022 | 1.081M |
| December 31, 2021 | 0.878M |
| September 30, 2021 | 0.658M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.658M
Minimum
Sep 2021
1.821M
Maximum
Mar 2023
1.418M
Average
1.516M
Median
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 28.53M |
| Retractable Technologies Inc | 0.654M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 2.145M |
| Catheter Precision Inc | 0.219M |